Article archive / November 2021
Originally published: . Volume 12, No. 11. Source pages: 5.
A 5-minute, computerized cognitive assessment that is completed using an iPad has been given the okay by the US Food and Drug Administration. Developed by Cognetivity Neurosciences Ltd, CognICA the test, now with clearance by the FDA to market, is a cognitive assessment for the early detection of dementia. The test offers several advantages over traditional pen-and- paper-based cognitive tests, Cognetivity officials said in a news release. "These include its high sensitivity to early-stage cognitive impairment, avoidance of cultural or educational bias and absence of learning effect upon repeat testing," the Cognetivity officials stated. According to the Alzheimer’s Association, more than 6 million Americans are now living with Alzheimer's disease, and will increase to 12.7 million by 2050. Cognetivity officials ssid that because the test runs on a computer, it can support remote, self-administered testing at scale and is geared toward seamless integration with existing electronic health record systems.
This article is part of a historical newspaper archive. Read the original issue for its original layout, photographs and graphics.